NTLA-2001
Intellia Therapeutics
['cardio', 'cardiomyopathy', 'crispr']
intellia $ntla presents updated interim data from the cardiomyopathy arm of ongoing phase 1 study of ntla-2001, an investigational crispr therapy for the treatment of attr amyloidosis at #aha22 
Biotellytics / https://t.co/37itIfRolp = business intel service on listed European Bios / Views=mine only, RT-like=/=endorse, no advice. 16y in Tech (chip design)